Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构：
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP03.03-02
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [42] Non-small Cell Lung Cancer Survival Estimation Through Multi-omic Two-layer SVM: A Multi-omics and Multi-Sources Integrative Model
    Manganaro, Lorenzo
    Sabbatini, Gianmarco
    Bianco, Selene
    Bironzo, Paolo
    Borile, Claudio
    Colombi, Davide
    Falco, Paolo
    Primo, Luca
    Vattakunnel, Shaji
    Bussolino, Federico
    Scagliotti, Giorgio Vittorio
    CURRENT BIOINFORMATICS, 2023, 18 (08) : 658 - 669
  • [43] Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
    Cristina Julian
    Navdeep Pal
    Anda Gershon
    Marie Evangelista
    Hans Purkey
    Peter Lambert
    Zhen Shi
    Qing Zhang
    BMC Cancer, 23
  • [44] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [45] Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis
    Lin, Lanlan
    Yang, Fan
    Lin, Guofu
    Chen, Xiangqi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02) : 210 - 218
  • [46] Non-small cell lung cancer in China
    Chen, Peixin
    Liu, Yunhuan
    Wen, Yaokai
    Zhou, Caicun
    CANCER COMMUNICATIONS, 2022, 42 (10) : 937 - 970
  • [47] Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
    Julian, Cristina
    Pal, Navdeep
    Gershon, Anda
    Evangelista, Marie
    Purkey, Hans
    Lambert, Peter
    Shi, Zhen
    Zhang, Qing
    BMC CANCER, 2023, 23 (01)
  • [48] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [49] Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
    Abascal, Jensen
    Oh, Michael S.
    Liclican, Elvira L.
    Dubinett, Steven M.
    Salehi-Rad, Ramin
    Liu, Bin
    CELLS, 2023, 12 (19)
  • [50] Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival
    Ye, Qing
    Hickey, Justin
    Summers, Kathleen
    Falatovich, Brianne
    Gencheva, Marieta
    Eubank, Timothy D. D.
    Ivanov, Alexey V. V.
    Guo, Nancy Lan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
12345